UNAIDS welcomes South Africa’s Lenacapavir HIV prevention launch

Kiswahili

UNAIDS has welcomed South Africa’s rollout of Lenacapavir as a landmark step in HIV prevention. The injectable is now available at 360 public health facilities across six provinces. The drug has also been added to the national essential medicines list.

South Africa launched the Lenacapavir HIV prevention programme on 6 June 2026. UNAIDS described the development as a landmark achievement for the country. The injectable is currently available at 360 public health facilities in six provinces. Officials have added the drug to South Africa’s essential medicines list. UNAIDS highlighted the rollout as an important measure to expand access to effective HIV prevention options.

Makala yanayohusiana

A volunteer receiving a needle-free vaccine in a lab with AI-designed virus models in the background.
Picha iliyoundwa na AI

AI-designed “pan-sarbecovirus” vaccine candidate reports early safety and immune-response signals in first human trial

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

A needle-free, DNA-based vaccine candidate designed using machine-learning methods has completed a first-in-human Phase 1 study in the UK, with researchers reporting it was well tolerated and induced immune responses against multiple viruses in the sarbecovirus group, which includes SARS-CoV, SARS-CoV-2 and related bat coronaviruses.

US Pepfar cuts continue to threaten lenacapavir rollout in South Africa

A new NGO report warns that lingering effects of 2025 US Pepfar funding cuts are undermining South Africa's rollout of the six-monthly HIV prevention injection lenacapavir, despite recent US funding restoration efforts and initial shipments. Community infrastructure losses hinder uptake among high-risk groups, even as rollout begins late May.

New HIV pill simplifies treatment for complex cases

Imeripotiwa na AI

A new combination pill containing bictegravir and lenacapavir shows promise for people with HIV who require complex regimens. The phase three ARTISTRY 1 study found it performed as well as existing multi-pill options. Experts note its impact in South Africa will likely remain limited.

Siasa

Ramaphosa says NHI key to bridging public-private healthcare gap

Asia

Nadda chairs meeting on Ebola preparedness

America

Fiocruz starts full national production of tacrolimus for transplants

Study confirms tenth HIV cure case via stem cell transplant

A study published on Monday in Nature Microbiology confirms long-term HIV remission in the «Oslo patient», a 62-year-old man treated for myelodysplasia via stem cell transplant from his brother carrying the CCR5 Delta 32 mutation. He has been off antiretrovirals for four years with no detectable virus. This brings the total to ten patients deemed cured this way.

Jumatatu, 1. Mwezi wa sita 2026, 23:11:43

South africa rolls out unprecedented foot and mouth disease vaccination drive

Jumatatu, 18. Mwezi wa tano 2026, 12:57:17

South Africa assesses low risk from new Ebola outbreak

Jumatatu, 18. Mwezi wa tano 2026, 04:27:24

CAR-T cell therapy shows early promise for HIV control

Jumamosi, 2. Mwezi wa tano 2026, 23:24:40

Axel Kicillof announces boost in medication delivery in Buenos Aires

Jumanne, 24. Mwezi wa tatu 2026, 09:05:58

Deputy president highlights TB progress on World TB Day

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa